Authors: Rizvi, Syed Mohd. Danish
Shaikh, Sibhghatulla
Waseem, Shah Mohammad Abbas
Shakil, Shazi
Abuzenadah, Adel M.
Biswas, Deboshree
Tabrez, Shams
Ashraf, Ghulam Md.
Kamal, Mohammad Amjad
Title: Role of anti-diabetic drugs as therapeutic agents in Alzheimer's disease
Language (ISO): en
Abstract: Recent data have suggested a strong possible link between Type 2 Diabetes Mellitus and Alzheimer’s disease (AD), although exact mechanisms linking the two are still a matter of research and debate. Interestingly, both are diseases with high incidence and prevalence in later years of life. The link appears so strong that some scientists use Alzheimer’s and Type 3 Diabetes interchangeably. In depth study of recent data suggests that the anti diabetic drugs not only have possible role in treatment of Alzheimer’s but may also arrest the declining cognitive functions associated with it. The present review gives an insight into the possible links, existing therapeutics and clinical trials of anti diabetic drugs in patients suffering from AD primarily or as co-morbidity. It may be concluded that the possible beneficial effects and usefulness of the current anti diabetic drugs in AD cannot be neglected and further research is required to achieve positive results. Currently, several drug trials are in progress to give conclusive evidence based data.
Subject Headings: Alzheimer’s disease
anti-diabetic drugs
amyloid beta
beta-secretase
sodium glucose
co-transporters
Type 2 Diabetes Mellitus
URI: http://hdl.handle.net/2003/34994
http://dx.doi.org/10.17877/DE290R-17042
Issue Date: 2015-05-19
Rights link: http://creativecommons.org/licenses/by/4.0/
Appears in Collections:Review Articles

Files in This Item:
File Description SizeFormat 
Shakil_19052015_proof.pdfDNB241.14 kBAdobe PDFView/Open


This item is protected by original copyright



This item is licensed under a Creative Commons License Creative Commons